A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) (NCT04811560)

🔬

Loading study...

A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) (NCT04811560) | TrialReferrals